Early test suggests dengue vaccine possible

Published



LONDON (AP) — Results from an early test of a dengue vaccine suggest it isn’t ideal, but scientists say the study is still encouraging news in the global fight against the disease known as “break-bone fever.”

There is currently no treatment or vaccine for dengue, which causes symptoms including fever, severe joint pain, headache and bleeding. The mosquito-borne disease infects up to 100 million people worldwide every year, mostly in Asia, Africa and Latin America.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.